Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
05/2003
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042384A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof
05/22/2003WO2003042377A1 Expansion of t cells in vitro and expanded t cell populations
05/22/2003WO2003042375A1 Stem cells originating in salivary duet epithelial cells and use thereof
05/22/2003WO2003042368A2 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003WO2003042244A2 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003WO2003042171A1 Vitamin d derivatives with acyloxy groups at the 24-position of the side chain, a method for producing the same and use thereof in production of medicaments
05/22/2003WO2003042113A1 Production of cell suspensions
05/22/2003WO2003041758A1 Nerve repair unit and method of producing it
05/22/2003WO2003041654A2 Anti-estrogen and immune modulator combinations for treating breast cancer
05/22/2003WO2003041634A2 Bag system for cryopreservation of body fluids
05/22/2003WO2003041568A2 A three-dimensional matrix for producing living tissue equivalents
05/22/2003WO2003041560A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003WO2003027247A3 Modulation of stem cells using zinc finger proteins
05/22/2003WO2003008554A3 Methods and compositions for cell therapy
05/22/2003WO2002072754A3 Mva expressing modified hiv envelope, gag, and pol genes
05/22/2003US20030097665 To produce phosphorylated lysosomal proteins which are incorporated into pharmaceutical formulations for use in enzyme replacement therapy
05/22/2003US20030096740 A dental enamel proteins used as therapeutic or prophylactic agents for the treatment or prevention of cancer or tumor
05/22/2003US20030096411 Novel long-term three-dimensional tissue culture system
05/22/2003US20030096410 Methodology for constructing human / goat chimeras for the production of human cells
05/22/2003US20030096408 Support for use in the implantation of cells in mammal
05/22/2003US20030096407 Construction of an artificial uterus; provide biocompatible matrix, prefuse with cell population, culture cells, recover artificial uterine tissue
05/22/2003US20030096406 Tissue engineered uterus
05/22/2003US20030096404 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
05/22/2003US20030096397 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
05/22/2003US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders
05/22/2003US20030096016 Methods of kidney transplantation utilizing developing nephric tissue
05/22/2003US20030096015 Treating colon cancer with a mixture of 50% proteins-rich food, 30% lipids-rich food and 20% carbohydrates-rich food; e.g., 25% soybeans, 15% milk, 10% vegetables, 30% butter fats, 15% whole wheat and 5% fruits.
05/22/2003US20030096002 Delivery system for biological component
05/22/2003US20030095989 Chimeric cytolytic viruses for cancer treatment
05/22/2003US20030095956 Methods of proliferating undifferentiated neural cells
05/22/2003US20030095955 Provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.
05/22/2003US20030095954 Growth factor gene fused with secretory signal sequence is introduced into fibroblasts ex-vivo using adenovirus vector; infecting cultured non-hematocytes with the vector; administering the cells
05/22/2003US20030095952 Multi-organ engraftment with a single bone marrow-derived stem cell
05/22/2003US20030095950 Trace minerals solution containing organic mineral elements; an Acidophilus sp. innoculum; vitamin A, vitamin D, and folic acid; cobalt amino acid chelates; and dried kelp,
05/22/2003US20030095947 Compositions and methods for elimination of unwanted cells
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2472019A1 Production of cell suspensions
05/22/2003CA2468171A1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003CA2467258A1 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same.
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2466769A1 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/21/2003WO2004041156A2 Method for determining sensitivity to a bacteriophage
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312670A1 Method of extensive culture of antigen-specific cytotoxic t cells
05/21/2003EP1312667A1 Probiotics products containing lactic acid bacterium
05/21/2003EP1312375A1 Composition having anticancer activity
05/21/2003EP1312371A1 Animal papilla disinfectants and method of improving microbial environment
05/21/2003EP1312370A1 Composition comprising dried whole egg for treating hepatitis
05/21/2003EP1311691A2 Method and compositions for promoting osteogenesis
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311658A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
05/21/2003EP1311656A1 Use of bioactive glass compositions to stimulate osteoblast production
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1248640A4 Preparation and xenotransplantation of porcine islets
05/21/2003EP1142578B1 Method for producing an antitumoral agent and antitumoral agent thus obtained
05/21/2003EP0918528B1 Use of hyperimmunized milk and/or egg for treating gastrointestinal damage
05/21/2003EP0845939B1 Lysosomal proteins produced in the milk of nonhuman transgenic animals
05/21/2003EP0817640B1 Use of epithelial adhesive lactobacilli
05/21/2003CN1419597A Simultaneous stimulation and concentration of cells
05/21/2003CN1419588A A natural fluorescent dye obtained from a marine invertebrate, compositions from a marine invertebrate, compositions containing the said dye and their use
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419454A Use of lactic acid bacterium for the treatment of peritonitis
05/21/2003CN1418693A Oral liquid medicine for treating stomach-pain, and its prepn. method
05/21/2003CN1418692A Oral liquid for replenishing vital essence, removing dryness and reducing glucose and preparation process thereof
05/21/2003CN1418683A Medicine composition for treating mammary gland proliferation, and its prepn. method
05/21/2003CN1418682A Medicine compositions for treating biliary calculus, and its prepn. method
05/21/2003CN1418681A Medicine compositions for treating head-ache, and its prepn. method
05/21/2003CN1418680A Medicine composition for treating uterus tumour
05/21/2003CN1418658A Traditional Chinese medicine prepn. for treating acute and chronic bronchitis, and its prepn. method
05/21/2003CN1418651A Strengthening-bone bills contg. cortex Eucommiae for treating RD
05/21/2003CN1418650A Spray agent for treating tendon and bone injury
05/21/2003CN1418648A Medicine for treating hepatitis
05/21/2003CN1418645A Traditional Chinese medicine powder with functions of activating channels, relieving pain, dispelling wind-evil and strengthening-bone
05/21/2003CN1418643A Method for bathing with traditional Chinese medicine for anti human immunodeficiency virus and improving immunity
05/21/2003CN1418642A Process for prodn. of biological prepn. for antisenesence
05/21/2003CN1418579A Instant, full content and emulsion type aviduct fat of the froest frog, and its producing method
05/21/2003CN1108813C Detoxicating stasis-dispersing inflammation-relieving antalgic and refreshing medicine and its preparing process
05/21/2003CN1108808C Traditional Chinese medicine for treating male aciesis
05/21/2003CN1108804C Diabetes treating medicine and its prepn. method
05/21/2003CN1108803C Medicine for treating piles and its preparing process
05/21/2003CN1108802C Pharmaceutical prescription for treating psoriasis
05/21/2003CA2474159A1 Method for determining sensitivity to a bacteriophage
05/20/2003WO2003044037A2 Process for the manufacture of human mononuclear phagocytic leukocytes
05/20/2003US6566504 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566127 Enzymatic nucleic acid for use in the treatment of tumors, vision defects, arthritis and skin disorders
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6566046 Platelet storage media mixture of sodium chloride, sodium citrate, sodium acetate, sodium phosphate ans psoralen
05/20/2003US6565884 Bone graft material incorporating demineralized bone matrix and lipids
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 1259